# Charles Erlichman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/charles-erlichman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,734 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 70 |
| i10-index | 215 |
| Last Known Institution | Roswell Park Comprehensive Cancer Center |
| OpenAlex ID | https://openalex.org/A5022511085 |
| Works | 454 |

## Researcher papers

- [Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)](https://scholariq.org/papers/antitumor-activity-of-nivolumab-in-recurrent-and-metastatic-nasopharyngeal/)
- [Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study](https://scholariq.org/papers/efficacy-of-pazopanib-in-progressive-radioiodine-refractory-metastatic/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Roswell Park Comprehensive Cancer Center](https://scholariq.org/institutions/roswell-park-comprehensive-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.